- Home
- ONDS vs BRNS Comparison
ONDS vs BRNS Comparison
Compare ONDS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONDS
- BRNS
- Stock Information
- Founded
- ONDS 2014
- BRNS 2016
- Country
- ONDS United States
- BRNS United Kingdom
- Employees
- ONDS N/A
- BRNS N/A
- Industry
- ONDS Telecommunications Equipment
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- ONDS Telecommunications
- BRNS Health Care
- Exchange
- ONDS Nasdaq
- BRNS Nasdaq
- Market Cap
- ONDS 326.8M
- BRNS 36.0M
- IPO Year
- ONDS N/A
- BRNS 2021
- Fundamental
- Price
- ONDS $2.31
- BRNS $1.02
- Analyst Decision
- ONDS Strong Buy
- BRNS Strong Buy
- Analyst Count
- ONDS 2
- BRNS 1
- Target Price
- ONDS $3.25
- BRNS $3.00
- AVG Volume (30 Days)
- ONDS 21.6M
- BRNS 18.3K
- Earning Date
- ONDS 08-13-2025
- BRNS 08-07-2025
- Dividend Yield
- ONDS N/A
- BRNS N/A
- EPS Growth
- ONDS N/A
- BRNS N/A
- EPS
- ONDS N/A
- BRNS N/A
- Revenue
- ONDS $10,815,867.00
- BRNS $14,969,000.00
- Revenue This Year
- ONDS $243.35
- BRNS N/A
- Revenue Next Year
- ONDS $118.81
- BRNS N/A
- P/E Ratio
- ONDS N/A
- BRNS N/A
- Revenue Growth
- ONDS N/A
- BRNS 4381.74
- 52 Week Low
- ONDS $0.54
- BRNS $0.64
- 52 Week High
- ONDS $3.40
- BRNS $1.58
- Technical
- Relative Strength Index (RSI)
- ONDS 73.27
- BRNS 57.82
- Support Level
- ONDS $1.71
- BRNS $0.90
- Resistance Level
- ONDS $2.02
- BRNS $1.10
- Average True Range (ATR)
- ONDS 0.22
- BRNS 0.06
- MACD
- ONDS 0.02
- BRNS 0.01
- Stochastic Oscillator
- ONDS 85.79
- BRNS 65.52
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.